Clinical Oncology Next Generation Sequencing Market Likely To Witness Exponential Growth In The Industry | Thermo Fisher Scientific (Qiagen), Oxford Nanopore Technologies, QIAGEN

The global clinical oncology next generation sequencing market size is expected to grow from $0.36 billion in 2021 to $0.39 billion in 2022 at a compound annual growth rate (CAGR) of 9.7%. The global clinical oncology NGS market size is expected to grow to $0.68 billion in 2026 at a CAGR of 14.7%.

The Business Research Company offers the Clinical Oncology Next Generation Sequencing Global Market Report 2022 in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market's historic and forecast growth, and highlights important trends and strategies that players in the market can adopt.

Request FREE SAMPLE COPY of this research study:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3344&type=smp

The clinical oncology next-generation sequencing market consists of sales of devices and equipment used in clinical oncology next-generation sequencing and related services by entities (organizations, sole traders, and partnerships) that manufacture clinical oncology next-generation sequencing equipment. Next-generation sequencing is a process used to determine the sequence of nucleotides in a section of DNA and is used for oncology research. Only goods and services traded between entities or sold to end consumers are included.

Some key clinical oncology next generation sequencing market players are Thermo Fisher Scientific (Qiagen), Oxford Nanopore Technologies, QIAGEN, Myriad Genetics, Illumina, F. Hoffmann-La Roche, Perkin Elmer, Agilent Technologies, Pacific Bioscience, and Caris Life Sciences.

The countries covered in the global clinical oncology next generation sequencing market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam.

The regions covered in the global clinical oncology next generation sequencing market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Clinical Oncology Next Generation Sequencing Market Segmentation:

By Technology
1. Ion Semiconductor Sequencing
2. Pyro-Sequencing Synthesis Sequencing
3. Real Time Sequencing
4. Ligation Sequencing
4. Reversible Dye Termination Sequencing
5. Nano-Pore Sequencing

By Application
1. Screening
2. Companion Diagnostics

By End-User
1. Hospital Laboratories
2. Clinical Research Organizations
3. Diagnostic Laboratories

See more on the report at https://www.thebusinessresearchcompany.com/report/clinical-oncology-next-generation-sequencing-global-market-report

The Report's Table Of Contents includes
1. Executive Summary
2. Clinical Oncology Next Generation Sequencing Market Characteristics
3. Clinical Oncology Next Generation Sequencing Market Trends And Strategies
4. Impact Of COVID-19 On Clinical Oncology Next Generation Sequencing
5. Clinical Oncology Next Generation Sequencing Market Size And Growth
……
26. Africa Clinical Oncology Next Generation Sequencing Market
27. Clinical Oncology Next Generation Sequencing Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Clinical Oncology Next Generation Sequencing Market
29. Clinical Oncology Next Generation Sequencing Market Future Outlook and Potential Analysis
30. Appendix

This report covers the trends and market dynamics of the clinical oncology next generation sequencing market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.

Directly purchase the report here: https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3344

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Check out our blog: http://blog.tbrc.info/
And follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

About Us:
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that excels in company, market, and consumer research. It has published over 3000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

This release was published on openPR.